Related Experiment Video
Updated: May 5, 2026

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
Published on: October 16, 2015
Unravelling the Interaction Mechanism Between Oryzanol and Human Serum Albumin: An Integrated Approach Using
Chenge Zhang1, Siyi Zhu1, Shanshan Duan1
1College of Food Science and Engineering, Collaborative Innovation Center for Modern Grain Circulation and Safety, Nanjing University of Finance and Economics, Nanjing 210023, China.
Gamma-oryzanol (Ory) forms a stable complex with human serum albumin (HSA), primarily through hydrogen bonding and van der Waals forces. This interaction occurs at site I of HSA, offering insights into Ory
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Gamma-oryzanol (Ory) is a bioactive compound from rice bran oil, known for antioxidant and cholesterol-lowering effects.
- Understanding its interaction with human serum albumin (HSA) is crucial for its therapeutic applications.
Purpose of the Study:
- To investigate the molecular mechanisms of interaction between gamma-oryzanol (Ory) and human serum albumin (HSA).
- To elucidate the binding site and stability of the HSA-Ory complex.
Main Methods:
- Fluorescence quenching assays
- Thermodynamic analyses
- Molecular dynamics simulations
- Molecular docking
- MM-PBSA calculations
- Competitive site marker experiments
- Steered molecular dynamics simulations
Main Results:
- Ory quenches HSA fluorescence via a mixed mechanism, forming a stable complex.
- The HSA-Ory complex is stabilized by hydrogen bonding and van der Waals interactions.
- Ory specifically binds to site I of HSA, interacting with residues like Trp214 and Lys199.
- Steered molecular dynamics revealed the role of specific residues in Ory dissociation from HSA.
Conclusions:
- Gamma-oryzanol (Ory) forms a stable complex with human serum albumin (HSA) at site I.
- The binding is primarily mediated by hydrogen bonds and van der Waals forces.
- This study provides detailed molecular insights into the HSA-Ory interaction mechanism.
More Related Videos
Related Concept Videos
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Distribution: Plasma Protein Binding
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

